Anemia: A significant cardiovascular mortality risk after ST-segment elevation myocardial infarction complicated by the comorbidities of hypertension and kidney disease.
Wei-Chieh LeeHsiu-Yu FangHuang-Chung ChenChien-Jen ChenCheng-Hsu YangChi-Ling HangChiung-Jen WuChih-Yuan FangPublished in: PloS one (2017)
Anemia is a marker of an increased risk in one-year cardiovascular mortality in patients with STEMI. If the patients have comorbidities such as hypertension, or CKD, the effect of anemia is very significant.
Keyphrases
- chronic kidney disease
- end stage renal disease
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- blood pressure
- iron deficiency
- ejection fraction
- newly diagnosed
- prognostic factors
- acute coronary syndrome
- peritoneal dialysis
- cardiovascular events
- risk factors
- patient reported outcomes
- arterial hypertension